Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Revenue

Kiniksa Pharmaceuticals International, had revenue of $112.21M in the quarter ending September 30, 2024, with 67.37% growth. This brings the company's revenue in the last twelve months to $384.10M, up 54.41% year-over-year. In the year 2023, Kiniksa Pharmaceuticals International, had annual revenue of $270.26M with 22.74% growth.

• Revenue (ttm): $384.10M
• Revenue Growth: +54.41%
• P/S Ratio: 3.42
• Revenue / Employee: $1,293,259
• Employees: 297
• Market Cap: 1.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	270.26M	50.08M	22.74%
Dec 31, 2022	220.18M	181.64M	471.24%
Dec 31, 2021	38.54M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.